Skip to main content
. 2015 Jun 10;6(27):24205–24217. doi: 10.18632/oncotarget.4434

Figure 3. Heat map distribution of MAPK pathway gene mutations among MM/PCL patients.

Figure 3

The rows correspond to the indicated genes, and columns represent individual MM or PCL samples, which are colour-coded on the basis of gene status (white: wild-type; light red: Sanger-undetectable mutations; dark red: Sanger-detectable mutations).

HHS Vulnerability Disclosure